DP Technology has secured 800 million yuan (US$114 million) in Series C funding to scale its AI-for-...
The AMW Read
Updates the player map for the AI-for-Science vertical with a significant Series C round for DP Technology's molecular simulation tools.
NoveltySignificance
Healthcare & Bio · Player Map
DP Technology has secured 800 million yuan (US$114 million) in Series C funding to scale its AI-for-Science infrastructure. The firm uses tools like SciMaster and Piloteye to automate molecular simulations for battery and drug design. This investment marks a transition where AI becomes a foundational operating system for material and life sciences. By digitizing physics via the Particle Universe model, researchers are bypassing trial-and-error bottlenecks at an industrial scale. This shift will permanently accelerate global scientific discovery. 🚀🧪🔋
